TrialPloS one2013

Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial.

Lynn T Matthews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.